U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Emerging Infectious Diseases

CDC Stacks Public Health Publications

Emerging Infectious Diseases (EID) is a peer-reviewed, monthly journal published by the Centers for Disease Control and Prevention (CDC). It offers the latest scientific information on emerging infectious diseases and trends. Emerging Infectious Diseases is freely available to the public as Diamond Open Access. For more on EID, visit https://wwwnc.cdc.gov/eid.

(1)
(298)
(338)
(552)
(470)
(665)
(520)
(522)
(529)
(508)
(549)
(530)
(503)
(519)
(590)
(545)
(575)
(554)
(510)
(513)
(499)
(522)
(375)
(338)
(248)
(132)
(184)
(149)
(95)
(82)
(52)
0 of 31
(1)
(11379)
(6)
(940)
(366)
0 of 5
(13)
(93)
(6)
(7)
(4)
(7)
(46)
(22)
(8)
(24)
(2)
(11)
(1)
(15)
(1)
(3)
(17)
(17)
(1)
(1)
(3)
(3)
(17)
(52)
(39)
(11)
(3)
(65)
(3)
(21)
(2)
(7)
(4)
(1)
(178)
(27)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(77)
(1)
(1)
(2)
(42)
(1)
(26)
(1)
(5)
(1)
(23)
(3)
(1)
(4)
(14)
(1)
(1)
(322)
(2)
(30)
(1)
(1)
(1)
(1)
(8)
(19)
(4)
(1)
(134)
(1)
(1)
(51)
(43)
(129)
(1)
(3)
(16)
(22)
(8)
(10)
(15)
(1)
(1)
(48)
(566)
(1)
(40)
(30)
(1)
(8)
(12)
(23)
(1)
(10)
(5)
(1)
(5)
(14)
(1)
(15)
(1)
(11)
(1)
(1)
(1)
(3)
(2)
(64)
(39)
(1)
(1)
(2)
(1)
(11)
(5)
(2)
(14)
(1)
(13)
(38)
(1)
(1)
(61)
(5)
(1)
(5)
(1)
(39)
(1)
(261)
(5)
(13)
(5)
(5)
(56)
(1)
(50)
(285)
(27)
(27)
(3)
(46)
(19)
(1)
(234)
(1)
(1)
(1)
(38)
(22)
(46)
(2)
(6)
(1)
(5)
(15)
(36)
(2)
(4)
(59)
(12)
(1)
(4)
(89)
(17)
(3)
(8)
(1)
(26)
(188)
(7)
(1)
(6)
(1)
(6)
(45)
(11)
(25)
(10)
(7)
(75)
(109)
(10)
(230)
(8)
(8)
(1)
(13)
(7)
(92)
(4)
(2)
(2)
(1)
(1)
(7)
(3)
(21)
(16)
(2)
(5)
(3)
(26)
(2)
(2)
(10)
(2)
(1)
(8)
(15)
(1)
(4)
(2)
(35)
(1)
(7)
(33)
(28)
(1)
(13)
(1)
(1)
(1)
(7)
(2)
(30)
(26)
(12)
(5)
(5)
(2)
(4)
(1)
(1)
(96)
(2)
(24)
(1)
(8)
(1)
(18)
(7)
(1)
(1)
(40)
(7)
(16)
(1)
(16)
(12)
(19)
(12)
(34)
(7)
(4)
(17)
(128)
(3)
(2)
(5)
(15)
(2)
(1)
(4)
(21)
(16)
(1)
(2)
(17)
(1)
(69)
(1)
(1)
(7)
(70)
(47)
(10)
(7)
(57)
(1)
(59)
(23)
(3)
(1)
(3)
(1)
(1)
(9)
(13)
(5)
(1)
(1)
(2)
(30)
(8)
(4)
(3)
(45)
(19)
(3)
(2)
(14)
(20)
(18)
(1)
(3)
(2)
(5)
(2)
(1)
(12)
(1)
(3)
(38)
(1)
(2)
(9)
(18)
(8)
(1)
(33)
(58)
(4)
(1)
(22)
(1)
(10)
(18)
(24)
(1)
(28)
(5)
(19)
(19)
(163)
(1)
(14)
(8)
(9)
(59)
(5)
(1)
(1)
(1)
(9)
(1)
(3)
(48)
(1)
(16)
(1)
(40)
(3)
(1)
(10)
(3)
(40)
(49)
(1)
(6)
(11)
(13)
(138)
(36)
(1)
(2)
(4)
(3)
(9)
(1)
(11)
(10)
(176)
(1)
(29)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(31)
(37)
(9)
(1)
(82)
(4)
(44)
(1)
(1)
(27)
(84)
(143)
(1)
(9)
(2)
(9)
(1)
(1)
(2)
(1)
(2)
(16)
(8)
(1)
(73)
(9)
(14)
(103)
(881)
(3)
(12)
(3)
(18)
(5)
(2)
(16)
(2)
(11)
(100)
(18)
(25)
(27)
(1)
(10)
(4)
(13)
(20)
(4)
(7)
(1)
(3)
(1)
(19)
(5)
0 of 441
(298)
(338)
(551)
(506)
(629)
(521)
(519)
(528)
(505)
(545)
(532)
(499)
(515)
(591)
(523)
(575)
(554)
(510)
(513)
(500)
(528)
(377)
(336)
(249)
(133)
(190)
(151)
(95)
(82)
(53)
0 of 30
(1019)
(946)
(933)
(967)
(942)
(977)
(1034)
(1034)
(1105)
(1065)
(1151)
(1123)
0 of 12
(18)
(155)
(69)
(57)
(28)
(23)
(19)
(84)
(21)
(23)
(1569)
(2669)
(103)
(21)
(19)
(22)
(1418)
(302)
(252)
(76)
(123)
(22)
(41)
(31)
(23)
(16)
(25)
(38)
(22)
(71)
(17)
(117)
(25)
(19)
(19)
(54)
(56)
(38)
(3984)
(93)
(189)
(23)
(41)
(57)
(25)
(86)
(741)
(105)
(20)
(153)
(20)
(27)
(54)
(38)
(631)
(86)
(19)
(51)
(78)
(73)
(140)
(37)
(17)
(19)
(131)
(138)
(68)
(23)
(24)
(19)
(45)
(48)
(27)
(25)
(46)
(39)
(22)
(19)
(32)
(19)
(24)
(21)
(29)
(25)
(37)
(33)
(31)
(165)
(26)
(544)
(203)
(76)
(17)
(60)
(169)
(57)
(136)
(16)
(20)
(46)
(56)
(230)
(28)
(97)
(49)
(40)
(18)
(141)
(18)
(37)
(46)
(36)
(84)
(109)
(209)
(35)
(19)
(17)
(16)
(66)
(28)
(24)
(20)
(18)
(212)
(60)
(25)
(18)
(68)
(21)
(20)
(19)
(18)
(107)
(16)
(39)
(64)
(32)
(25)
(27)
(139)
(37)
(41)
(62)
(16)
(30)
(26)
(62)
(38)
(21)
(89)
(217)
(17)
(63)
(143)
(296)
(17)
(119)
(22)
(82)
(20)
(25)
(36)
(31)
(37)
(16)
(162)
(37)
(51)
(27)
(1518)
(1232)
(53)
(151)
(23)
(17)
(87)
(24)
(61)
(17)
(27)
(60)
(16)
(38)
(123)
(34)
(21)
(39)
(126)
(110)
(38)
(23)
(181)
(190)
(542)
(25)
(21)
(133)
(31)
(24)
(107)
(48)
(26)
(28)
(21)
(476)
(40)
(30)
(22)
(21)
(36)
(396)
(197)
(21)
(38)
(31)
(29)
(19)
(21)
(20)
(30)
(27)
(148)
(186)
(38)
(29)
(51)
(28)
(68)
(66)
(23)
(16)
(16)
(45)
(55)
(66)
(20)
(26)
(175)
(27)
(139)
(19)
(32)
(18)
(28)
(32)
(68)
(20)
(20)
(154)
(23)
(26)
(18)
(27)
(24)
(16)
(44)
(57)
(1908)
(18)
(318)
(35)
(84)
(74)
(2079)
(365)
(277)
(20)
(19)
(18)
(50)
(16)
(38)
(163)
(18)
(47)
(16)
(46)
(16)
(152)
(272)
(48)
(17)
(46)
(37)
(322)
(31)
(90)
(31)
(244)
(43)
(45)
(60)
(38)
(90)
(21)
(16)
(57)
(26)
(61)
(141)
(18)
(70)
(20)
(25)
(22)
(35)
(26)
(26)
(47)
(40)
(25)
(48)
(30)
(83)
(36)
(44)
(46)
(51)
(46)
(21)
(29)
(17)
(43)
(28)
(19)
(59)
(33)
(41)
(27)
(50)
(118)
(22)
(75)
(18)
(105)
(24)
(175)
(73)
(29)
(29)
(31)
(19)
(69)
(62)
(107)
(65)
(33)
(29)
(17)
(16)
(25)
(126)
(47)
(52)
(19)
(98)
(17)
(28)
(65)
(24)
(31)
(52)
(27)
(201)
(274)
(3339)
(33)
(80)
(28)
(29)
(33)
(26)
(27)
(22)
(55)
(25)
(112)
(54)
(34)
(191)
(35)
(23)
(20)
(24)
(39)
(103)
(20)
(19)
(31)
(16)
(58)
(36)
(167)
(17)
(16)
(17)
(25)
(168)
(157)
(228)
(16)
(100)
(208)
(77)
(529)
(24)
(86)
(83)
(180)
(38)
(71)
(32)
(20)
(55)
(50)
(31)
(18)
(18)
(22)
(29)
(18)
(17)
(43)
(155)
(63)
(16)
(29)
(20)
(66)
(97)
(45)
(21)
(20)
(26)
(47)
(19)
(38)
(57)
(125)
(58)
(25)
(24)
(43)
(22)
(17)
(16)
(40)
(91)
(63)
(25)
(21)
(53)
(18)
(19)
(16)
(16)
(28)
(27)
(86)
(74)
(252)
(161)
(16)
(30)
(19)
(23)
(132)
(75)
(44)
(32)
(84)
(121)
(229)
(52)
(23)
(17)
(27)
(8856)
(21)
(17)
(35)
(21)
(36)
(16)
(31)
(116)
(155)
(110)
(47)
(595)
(21)
(1002)
(414)
(36)
(27)
(86)
(23)
(28)
(32)
(42)
(96)
(32)
(618)
(21)
(19)
(17)
(83)
(74)
(286)
(52)
(222)
(19)
(45)
(20)
(149)
(128)
(80)
(23)
(27)
(18)
(21)
(210)
(44)
(56)
(28)
(25)
(20)
(38)
(107)
(52)
(32)
(20)
(19)
(46)
(28)
(26)
(63)
(39)
(26)
(22)
(16)
(21)
(20)
(19)
(37)
(19)
(20)
(35)
(39)
(21)
(22)
(38)
(101)
(20)
(28)
(22)
(53)
(39)
(49)
(26)
(39)
(60)
(37)
(16)
(78)
(22)
(21)
(22)
(19)
(41)
(30)
(137)
(51)
(102)
(33)
(19)
(3454)
(33)
(16)
(61)
(27)
(34)
(68)
(19)
(58)
(27)
(23)
(27)
(44)
(19)
(33)
(55)
(27)
(24)
(32)
(25)
(51)
(22)
(114)
(216)
(553)
(20)
(2114)
(79)
(75)
(16)
(29)
(65)
(36)
(33)
(57)
(153)
(47)
(536)
(132)
(47)
(50)
(19)
(50)
(30)
(25)
(33)
(51)
(21)
(170)
(18)
(58)
(19)
(156)
(77)
(17)
(57)
(86)
(112)
(91)
(19)
(56)
(53)
(36)
(22)
(19)
(55)
(47)
(60)
(66)
(16)
(28)
(54)
(18)
(117)
(18)
(24)
(17)
(24)
(93)
(38)
(87)
(25)
(31)
(21)
(22)
(30)
(19)
(19)
(41)
(153)
(25)
(120)
(58)
(18)
(89)
(22)
(24)
(40)
(410)
(39)
(17)
(112)
(35)
(23)
(56)
(21)
(17)
(46)
(18)
(22)
(20)
(26)
(21)
(155)
(29)
(22)
(19)
(19)
(25)
(51)
(17)
(37)
(25)
(1517)
(30)
(51)
(40)
(56)
(56)
(45)
(35)
(77)
(45)
(50)
(41)
(37)
(18)
(21)
(25)
(161)
(19)
(18)
(19)
(17)
(539)
(17)
(68)
(72)
(30)
(39)
(23)
(20)
(633)
(113)
(23)
(107)
(19)
(207)
(18)
(105)
(589)
(30)
(17)
(21)
(45)
(21)
(22)
(24)
(19)
(140)
(35)
(21)
(21)
(273)
(62)
(26)
(231)
(71)
(64)
(20)
(66)
(95)
(17)
(44)
(82)
(37)
(27)
(26)
(35)
(23)
(92)
(26)
(50)
(69)
(44)
(46)
(34)
(25)
(21)
(43)
(19)
(25)
(1523)
(215)
(79)
(147)
(130)
(47)
(22)
(25)
(17)
(170)
(366)
(258)
(33)
(17)
(27)
(139)
(129)
(36)
(39)
(64)
(65)
(634)
(27)
(20)
(95)
(49)
(279)
(216)
(31)
(91)
(79)
(52)
(65)
(21)
(83)
(39)
(26)
(63)
(27)
(26)
(31)
(103)
(27)
(30)
(19)
(31)
(283)
(131)
(51)
(45)
(43)
(17)
(47)
(24)
(37)
(293)
(78)
(61)
(136)
(31)
(75)
(518)
(37)
(29)
(386)
(106)
(80)
(24)
(28)
(264)
(163)
(29)
(23)
(21)
(51)
(29)
(19)
(38)
(27)
(18)
(100)
(17)
(45)
(20)
(17)
(23)
(17)
(33)
(20)
(36)
(56)
(29)
(38)
(31)
(50)
(25)
(26)
(22)
(44)
(18)
(134)
(31)
(34)
(19)
(18)
(39)
(176)
(25)
(18)
(60)
(52)
(120)
(24)
(18)
(54)
(50)
(29)
(27)
(18)
(29)
(25)
(20)
(90)
(24)
(23)
(35)
(18)
(30)
(27)
(27)
(308)
(152)
(19)
(29)
(27)
(251)
(18)
(18)
(56)
(18)
(36)
(29)
(30)
(57)
(40)
(147)
(49)
(363)
(45)
(27)
(64)
(402)
(24)
(33)
(186)
(20)
(200)
(51)
(91)
(106)
(94)
(20)
(43)
(23)
(23)
(34)
(52)
(52)
(23)
(225)
(34)
(22)
(33)
(30)
(18)
(25)
(28)
(35)
(31)
(151)
(57)
(79)
(20)
(18)
(21)
(21)
(44)
(72)
(36)
(105)
(52)
(41)
(133)
(21)
(28)
(64)
(559)
(194)
(55)
(44)
(23)
(27)
(90)
(50)
(217)
(77)
(55)
(42)
(65)
(38)
(19)
(27)
(18)
(17)
(842)
(105)
(31)
(98)
(659)
(306)
(24)
0 of 1000
(8)
(10)
(9)
(8)
(8)
(9)
(12)
(7)
(10)
(16)
(12)
(11)
(7)
(7)
(15)
(7)
(22)
(7)
(7)
(11)
(13)
(8)
(7)
(10)
(7)
(8)
(7)
(10)
(15)
(9)
(8)
(13)
(8)
(7)
(8)
(7)
(9)
(8)
(10)
(7)
(10)
(7)
(9)
(10)
(9)
(10)
(11)
(11)
(10)
(10)
(8)
(8)
(7)
(50)
(7)
(7)
(9)
(10)
(7)
(7)
(9)
(15)
(8)
(8)
(7)
(8)
(10)
(7)
(7)
(12)
(8)
(10)
(11)
(9)
(8)
(7)
(14)
(11)
(9)
(7)
(17)
(8)
(8)
(7)
(8)
(14)
(10)
(11)
(7)
(7)
(10)
(10)
(10)
(9)
(12)
(7)
(9)
(13)
(90)
(23)
(20)
(10)
(15)
(15)
(8)
(8)
(26)
(8)
(12)
(11)
(9)
(7)
(7)
(11)
(17)
(7)
(8)
(7)
(14)
(9)
(7)
(14)
(11)
(7)
(11)
(8)
(27)
(13)
(9)
(8)
(8)
(11)
(10)
(8)
(7)
(15)
(12)
(9)
(10)
(7)
(10)
(7)
(11)
(7)
(8)
(21)
(12)
(7)
(14)
(12)
(8)
(7)
(9)
(9)
(8)
(7)
(11)
(7)
(7)
(9)
(11)
(7)
(9)
(8)
(11)
(20)
(10)
(8)
(10)
(18)
(16)
(7)
(10)
(10)
(17)
(8)
(10)
(17)
(13)
(13)
(12)
(8)
(7)
(9)
(47)
(8)
(7)
(10)
(10)
(7)
(8)
(13)
(7)
(8)
(11)
(11)
(7)
(9)
(27)
(11)
(9)
(15)
(7)
(9)
(12)
(8)
(8)
(20)
(9)
(18)
(8)
(7)
(9)
(8)
(8)
(11)
(9)
(9)
(12)
(7)
(7)
(15)
(8)
(9)
(9)
(7)
(7)
(15)
(21)
(8)
(8)
(34)
(14)
(64)
(9)
(12)
(7)
(12)
(8)
(9)
(11)
(8)
(8)
(14)
(8)
(10)
(9)
(11)
(7)
(8)
(8)
(8)
(9)
(11)
(7)
(15)
(7)
(14)
(7)
(22)
(11)
(8)
(8)
(8)
(8)
(12)
(7)
(8)
(7)
(9)
(17)
(10)
(10)
(23)
(8)
(9)
(18)
(7)
(8)
(7)
(8)
(9)
(13)
(11)
(7)
(9)
(9)
(16)
(16)
(10)
(18)
(9)
(27)
(12)
(10)
(7)
(15)
(8)
(13)
(9)
(8)
(9)
(7)
(12)
(7)
(11)
(9)
(7)
(14)
(9)
(8)
(19)
(7)
(15)
(10)
(7)
(25)
(12)
(11)
(8)
(7)
(11)
(9)
(8)
(10)
(10)
(7)
(8)
(7)
(7)
(9)
(7)
(12)
(10)
(8)
(11)
(7)
(11)
(7)
(15)
(16)
(28)
(10)
(7)
(9)
(9)
(7)
(7)
(8)
(26)
(8)
(10)
(9)
(8)
(8)
(15)
(11)
(8)
(16)
(11)
(29)
(17)
(9)
(15)
(8)
(7)
(8)
(30)
(12)
(7)
(8)
(8)
(11)
(7)
(8)
(8)
(17)
(11)
(7)
(7)
(12)
(8)
(8)
(8)
(37)
(7)
(7)
(11)
(11)
(10)
(10)
(7)
(16)
(7)
(19)
(7)
(9)
(7)
(15)
(8)
(12)
(9)
(9)
(7)
(8)
(31)
(7)
(7)
(8)
(7)
(7)
(7)
(14)
(10)
(8)
(18)
(9)
(8)
(7)
(7)
(16)
(7)
(13)
(8)
(12)
(8)
(10)
(11)
(8)
(8)
(9)
(8)
(11)
(8)
(10)
(17)
(13)
(7)
(8)
(9)
(7)
(8)
(17)
(11)
(7)
(7)
(8)
(9)
(7)
(8)
(8)
(7)
(7)
(7)
(9)
(12)
(10)
(11)
(11)
(8)
(13)
(21)
(7)
(7)
(11)
(9)
(9)
(7)
(10)
(9)
(11)
(13)
(12)
(8)
(13)
(16)
(13)
(11)
(7)
(7)
(18)
(7)
(20)
(20)
(7)
(7)
(10)
(7)
(8)
(20)
(8)
(13)
(10)
(8)
(14)
(10)
(11)
(11)
(10)
(19)
(36)
(8)
(12)
(14)
(9)
(9)
(17)
(10)
(7)
(17)
(7)
(9)
(7)
(7)
(7)
(11)
(14)
(7)
(7)
(9)
(13)
(7)
(22)
(21)
(7)
(13)
(7)
(7)
(7)
(8)
(17)
(16)
(7)
(12)
(10)
(8)
(11)
(12)
(8)
(9)
(7)
(9)
(17)
(7)
(10)
(7)
(8)
(7)
(7)
(7)
(24)
(17)
(9)
(8)
(7)
(8)
(11)
(11)
(7)
(15)
(22)
(8)
(8)
(7)
(8)
(22)
(13)
(17)
(7)
(16)
(8)
(9)
(20)
(17)
(10)
(12)
(9)
(8)
(31)
(9)
(8)
(9)
(15)
(15)
(7)
(7)
(10)
(7)
(10)
(10)
(7)
(8)
(8)
(12)
(17)
(7)
(10)
(10)
(9)
(7)
(8)
(7)
(7)
(24)
(7)
(9)
(7)
(8)
(7)
(9)
(7)
(8)
(8)
(8)
(17)
(18)
(8)
(10)
(17)
(15)
(10)
(7)
(7)
(34)
(11)
(10)
(7)
(16)
(9)
(14)
(8)
(7)
(9)
(9)
(8)
(7)
(8)
(10)
(7)
(7)
(15)
(10)
(15)
(7)
(7)
(14)
(10)
(9)
(8)
(19)
(9)
(11)
(16)
(19)
(7)
(8)
(15)
(12)
(8)
(12)
(8)
(7)
(12)
(15)
(7)
(12)
(9)
(10)
(7)
(7)
(8)
(8)
(10)
(8)
(7)
(39)
(12)
(9)
(14)
(12)
(7)
(11)
(9)
(7)
(21)
(16)
(7)
(7)
(14)
(13)
(19)
(16)
(8)
(7)
(9)
(7)
(15)
(15)
(9)
(32)
(12)
(19)
(8)
(7)
(34)
(22)
(14)
(27)
(8)
(23)
(11)
(11)
(7)
(49)
(8)
(8)
(9)
(7)
(13)
(8)
(11)
(9)
(7)
(9)
(9)
(7)
(13)
(43)
(13)
(9)
(7)
(7)
(15)
(7)
(8)
(21)
(10)
(7)
(7)
(20)
(11)
(7)
(8)
(7)
(9)
(18)
(7)
(9)
(25)
(25)
(16)
(7)
(18)
(10)
(129)
(8)
(7)
(12)
(9)
(7)
(8)
(8)
(8)
(14)
(7)
(9)
(11)
(15)
(151)
(7)
(7)
(7)
(8)
(8)
(7)
(10)
(10)
(12)
(13)
(15)
(8)
(23)
(8)
(8)
(8)
(9)
(8)
(7)
(12)
(35)
(9)
(8)
(49)
(7)
(7)
(8)
(16)
(12)
(7)
(7)
(33)
(7)
(8)
(17)
(9)
(7)
(9)
(8)
(9)
(9)
(9)
(10)
(7)
(17)
(8)
(32)
(7)
(8)
(8)
(21)
(10)
(19)
(13)
(7)
(9)
(16)
(9)
(10)
(9)
(11)
(9)
(14)
(8)
(11)
(7)
(12)
(20)
(8)
(7)
(7)
(10)
(8)
(11)
(14)
(16)
(18)
(7)
(9)
(7)
(7)
(7)
(7)
(14)
(10)
(16)
(21)
(7)
(10)
(9)
(10)
(15)
(9)
(8)
(7)
(7)
(11)
(18)
(11)
(7)
(26)
(21)
(19)
(11)
(9)
(9)
(15)
(13)
(10)
(8)
(24)
(18)
(10)
(14)
(8)
(27)
(9)
(8)
(9)
(11)
(8)
(33)
(9)
(11)
(11)
(11)
(9)
(14)
(10)
(10)
(10)
(8)
(8)
(10)
(18)
(11)
(27)
(13)
(11)
(10)
(8)
(10)
(9)
(8)
(10)
(12)
(28)
(8)
(29)
(10)
(8)
(12)
(21)
(10)
(10)
(21)
(8)
(14)
(8)
(8)
(24)
(14)
(15)
(8)
(18)
(16)
(8)
(8)
(13)
(9)
(9)
(19)
(8)
(8)
(14)
(16)
(30)
(26)
(20)
(19)
(17)
(8)
(12)
(12)
(11)
(10)
(9)
(10)
(11)
(22)
(8)
(10)
(8)
(9)
(13)
(8)
(15)
(8)
(13)
(8)
(9)
(13)
(12)
(8)
(18)
(10)
(13)
(12)
(9)
(9)
(8)
(8)
(9)
(8)
(22)
(8)
(8)
(8)
(17)
(9)
(34)
(9)
(10)
(12)
(12)
(11)
(9)
(8)
(9)
(9)
(8)
0 of 1000
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 468
(126)
(2)
(4)
(2)
(6)
(67)
(1)
(1)
(3)
(26)
(1)
(295)
(1)
(1)
(2)
(47)
(4)
(1)
(3)
(1)
(242)
(7)
(321)
(1346)
(19)
(9)
(10)
(1)
(1)
(10)
(2)
(3)
(2)
(7)
(8)
(2)
(6)
(2)
(73)
(1)
(69)
(1)
(1)
(1)
(19)
0 of 45
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(10)
(2)
(1)
(1)
(1)
(3)
(4)
(2)
(2)
(3)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(11)
(33)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(5)
(1)
(2)
(1)
(2)
(2)
(54)
(6)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(1)
(5)
(5)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(2)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(177)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(3)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(46)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(3)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(10)
(2)
(3)
(8)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(2)
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(4)
(4)
(1)
(1)
(2)
(6)
(2)
(2)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(26)
(1)
(1)
(47)
(3)
(4)
(2)
(6)
(3)
(1)
(2)
(4)
(2)
(2)
(1)
(72)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(8)
(5)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(2)
(3)
(2)
(2)
(6)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(16)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(3)
(1)
(7)
(1)
(1)
(2)
(3)
(1)
(20)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(26)
(1)
(1)
(4)
(4)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(4)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(16)
(1)
(2)
(13)
(1)
(2)
(3)
(1)
(19)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(2)
(5)
(4)
(2)
(2)
(8)
(25)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(15)
(2)
(2)
(1)
(4)
(1)
(1)
(15)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(4)
(1)
(1)
(3)
(3)
(2)
(1)
(2)
(2)
(1)
(2)
(1)
(2)
(5)
(2)
(6)
(46)
(5)
(4)
(3)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(2)
(1)
(2)
(7)
(1)
(1)
(15)
(2)
(71)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(5)
(2)
(3)
(3)
(1)
(1)
(2)
(4)
(1)
(5)
(1)
(2)
(2)
(1)
(2)
(33)
(1)
(1)
(1)
(29)
(4)
(5)
(2)
(2)
(5)
(5)
(1)
(8)
(7)
(1)
(2)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(7)
(2)
(1)
(1)
(2)
(6)
(2)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(6)
(2)
(2)
(2)
(1)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(44)
(3)
(1)
(1)
(16)
(1)
(4)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(2)
(1)
(3)
(1)
(7)
(3)
(2)
(2)
(6)
(4)
(1)
(1)
(19)
(5)
(4)
(5)
(1)
(18)
(6)
(2)
(1)
(6)
(4)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(6)
(7)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(19)
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(4)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(38)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(8)
(3)
(3)
(5)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(5)
(2)
(3)
(2)
(5)
(3)
(2)
(5)
(5)
(2)
(43)
(2)
(25)
(5)
(1)
(1)
(1)
(3)
(2)
(2)
(2)
(2)
(2)
(111)
(2)
(2)
(4)
(2)
(4)
(2)
(54)
(2)
(2)
(3)
(23)
(66)
(2)
(25)
(3)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(3)
(2)
(7)
(53)
(2)
(20)
(2)
(2)
(2)
(4)
(3)
(7)
(8)
(2)
(4)
(2)
(2)
(4)
(3)
(5)
(2)
(15)
(5)
(2)
(3)
(2)
(3)
(2)
(8)
(2)
(2)
(2)
(3)
(3)
(2)
(3)
(15)
(2)
(6)
(3)
(5)
(4)
(10)
(4)
(14)
(2)
(5)
(2)
(5)
(82)
(2)
(7)
(5)
(18)
(3)
(14)
(58)
(3)
(2)
(4)
(3)
(2)
(3)
(209)
(2)
(2)
(2)
(2)
(2)
(2)
(12)
(2)
(3)
(4)
(2)
(3)
(4)
(3)
(156)
(2)
(2)
0 of 1000
Showing 921 - 940 of 12467 results
  • Strongyloides Hyperinfection Syndrome among COVID19 Patients Treated with Corticosteroids
    Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
    Kim, Jani M. ;
    Sivasubramanian, Geetha
    7 2022 | Emerg Infect Dis. 2022; 28(7):1531-1533
    Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk pop ...
    Supporting Files Public Domain
  • Anncaliia algerae Microsporidiosis Diagnosed by Metagenomic NextGeneration Sequencing China
    Anncaliia algerae Microsporidiosis Diagnosed by Metagenomic Next-Generation Sequencing, China
    Liu, Chen ;
    Chen, Qin
    7 2022 | Emerg Infect Dis. 2022; 28(7):1466-1470
    We report a case of Anncaliia algerae microsporidia infection in an immunosuppressed kidney transplant recipient in China. Light microscopy and transmission electron microscopy initially failed to identify A. algerae, which eventually was detected by metagenomic next-generation sequencing. Our case highlights the supporting role of metagenomic sequ ...
    Supporting Files Public Domain
  • Natural History of and Dynamic Changes in Clinical Manifestation Serology and Treatment of Brucellosis China
    Natural History of and Dynamic Changes in Clinical Manifestation, Serology, and Treatment of Brucellosis, China
    Wang, Hongyu ;
    Liu, Hongyan
    7-2022 | Emerg Infect Dis. 2022; 28(7):1460-1465
    Serum agglutination test plus exposure history were used to diagnose most cases of human brucellosis in 2 China provinces. After appropriate treatment, 13.3% of acute brucellosis cases progressed to chronic disease; arthritis was an early predictor. Seropositivity can persist after symptoms disappear, which might cause physicians to subjectively ex ...
    Supporting Files Public Domain
  • Novel Mycobacterium tuberculosis Complex Genotype Related to M caprae
    Novel Mycobacterium tuberculosis Complex Genotype Related to M. caprae
    Shea, Joseph ;
    Smith, Carol
    7 2022 | Emerg Infect Dis. 2022; 28(7):1431-1436
    We report the unusual genotypic characterization of a bacterium isolated from a clinical sample of a patient who grew up in Bangladesh and lives in the United States. Using whole-genome sequencing, we identified the bacterium as a member of the Mycobacterium tuberculosis complex (MTBC). Phylogenetic placement of this strain suggests a new MTBC geno ...
    Supporting Files Public Domain
  • SelfReported and Physiologic Reactions to Third BNT162b2 mRNA COVID19 Booster Vaccine Dose
    Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
    Mofaz, Merav ;
    Yechezkel, Matan
    7 2022 | Emerg Infect Dis. 2022; 28(7):1375-1383
    Despite extensive technological advances in recent years, objective and continuous assessment of physiologic measures after vaccination is rarely performed. We conducted a prospective observational study to evaluate short-term self-reported and physiologic reactions to the booster BNT162b2 mRNA (Pfizer-BioNTech, https://www.pfizer.com) vaccine dose ...
    Supporting Files Public Domain
  • Analyzing and Modeling the Spread of SARSCoV2 Omicron Lineages BA1 and BA2 France September 2021February 2022
    Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022
    Sofonea, Mircea T. ;
    Roquebert, Bénédicte
    7-2022 | Emerg Infect Dis. 2022; 28(7):1355-1365
    We analyzed 324,734 SARS-CoV-2 variant screening tests from France enriched with 16,973 whole-genome sequences sampled during September 1, 2021-February 28, 2022. Results showed the estimated growth advantage of the Omicron variant over the Delta variant to be 105% (95% CI 96%-114%) and that of the BA.2 lineage over the BA.1 lineage to be 49% (95% ...
    Supporting Files Public Domain
  • The Scientist Who Described the Filarial ParasiteMansonella ozzardiin 1897
    The Scientist Who Described the Filarial Parasite Mansonella ozzardi in 1897
    Crainey, James Lee ;
    Suwa, Uziel Ferreira
    7-2022 | Emerg Infect Dis. 2022; 28(7):1499-1502
    No Description
    Supporting Files Public Domain
  • Suspected CattoHuman Transmission of SARSCoV2 Thailand JulySeptember 2021
    Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021
    Sila, Thanit ;
    Sunghan, Jutapoln
    7-2022 | Emerg Infect Dis. 2022; 28(7):1485-1488
    A veterinarian in Thailand was diagnosed with COVID-19 after being sneezed on by an infected cat owned by an infected patient. Genetic study supported the hypothesis of SARS-CoV-2 transmission from the owner to the cat, and then from the cat to the veterinarian.
    Supporting Files Public Domain
  • Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARSCoV2 Vaccination Japan
    Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
    Sato, Toshihiro ;
    Kodama, Shinjiro
    7-2022 | Emerg Infect Dis. 2022; 28(7):1518-1520
    Recently, along with increasing use of immune checkpoint inhibitors such as nivolumab, the incidence of immune-related adverse events, including type 1 diabetes mellitus, has become a serious problem. We report a patient who had immune checkpoint inhibitor‒associated type 1 diabetes mellitus that developed after a second mRNA-based SARS-CoV-2 vacci ...
    Supporting Files Public Domain
  • Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in Seawater
    Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in Seawater
    Desdouits, Marion ;
    Polo, David
    7-2022 | Emerging Infectious Diseases
    Little data on the persistence of human norovirus infectivity are available to predict its transmissibility. Using human intestinal enteroids, we demonstrate that 2 human norovirus strains can remain infectious for several weeks in seawater. Such experiments can improve understanding of factors associated with norovirus survival in coastal waters a ...
    Supporting Files Public Domain
  • Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults United States
    Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States
    Irish, Amanda ;
    Whitman, Jeffrey D.
    2022/07/01 | Emerg Infect Dis. 2022; 28(7):1313-1320
    We combined American Community Survey data with age-specific Trypanosoma cruzi prevalence derived from US surveys and World Health Organization reports to yield estimates of Chagas disease in the United States, which we mapped at the local level. In addition, we used blood donor data to estimate the relative prevalence of autochthonous T. cruzi inf ...
    Supporting Files
  • Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria France 20122020
    Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020
    McNamara, Kiara X. ;
    Perz, Joseph F.
    6 2022 | Emerg Infect Dis. 2022; 28(6):1303-1304
    No Description
    Supporting Files Public Domain
  • Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria France 20122020 In Response
    Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 [In Response]
    Daniau, Côme ;
    Berger-Carbonne, Anne
    6 2022 | Emerg Infect Dis. 2022; 28(6):1303-1304
    No Description
    Supporting Files Public Domain
  • Introduction and Rapid Spread of SARSCoV2 Omicron Variant and Dynamics of BA1 and BA11 Sublineages Finland December 2021
    Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
    Vauhkonen, Hanna ;
    Nguyen, Phuoc Truong
    6 2022 | Emerg Infect Dis. 2022; 28(6):1229-1232
    Multiple introductions of SARS-COV-2 Omicron variant BA.1 and BA.1.1. lineages to Finland were detected in early December 2021. Within 3 weeks, Omicron overtook Delta as the most common variant in the capital region. Sequence analysis demonstrated the emergence and spread through community transmission of a large cluster of BA.1.1 virus.
    Supporting Files Public Domain
  • AntimicrobialResistant Shigella spp in San Diego California USA 20172020
    Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017–2020
    Gaufin, Thaidra ;
    Blumenthal, Jill
    6 2022 | Emerg Infect Dis. 2022; 28(6):1110-1116
    Annually, Shigella spp. cause ≈188 million cases of diarrheal disease globally, including 500,000 cases in the United States; rates of antimicrobial resistance are increasing. To determine antimicrobial resistance and risk factors in San Diego, California, USA, we retrospectively reviewed cases of diarrheal disease caused by Shigella flexneri and S ...
    Supporting Files Public Domain
  • Dynamics of SARSCoV2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine
    Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine
    Fonseca, Marcela Helena Gambim ;
    Pinto, Ana Carolina Matias Dinelly
    6 2022 | Emerg Infect Dis. 2022; 28(6):1237-1240
    We evaluated the longitudinal dynamics of antibody response to the SARS-CoV-2 vaccine CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust antibody response after the second dose of CoronaVac that wanes over time. The response was recovered by BNT162b2, which boosted anti-spike antibody titers.
    Supporting Files Public Domain
  • Recombinant BA1BA2 SARSCoV2 Virus in Arriving Travelers Hong Kong February 2022
    Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022
    Gu, Haogao ;
    Ng, Daisy Y.M.
    6 2022 | Emerg Infect Dis. 2022; 28(6):1276-1278
    We studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021-February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5' end of the spike gene in 2 epidemiologically linked case-patients. Continued surveillance for SARS-CoV-2 recombinants is needed.
    Supporting Files Public Domain
  • Lyme Disease Anaplasmosis and Babesiosis Atlantic Canada
    Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada
    Allehebi, Ziyad O. ;
    Khan, Farhan M.
    6 2022 | Emerg Infect Dis. 2022; 28(6):1292-1294
    In July 2021, a PCR-confirmed case of locally acquired Babesia microti infection was reported in Atlantic Canada. Clinical features were consistent with babesiosis and resolved after treatment. In a region where Lyme disease and anaplasmosis are endemic, the occurrence of babesiosis emphasizes the need to enhance surveillance of tickborne infection ...
    Supporting Files Public Domain
  • Characterization of HealthcareAssociated and CommunityAssociated Clostridioides difficile Infections among Adults Canada 20152019
    Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019
    Du, Tim ;
    Choi, Kelly B.
    6 2022 | Emerg Infect Dis. 2022; 28(6):1128-1136
    We investigated epidemiologic and molecular characteristics of healthcare-associated (HA) and community-associated (CA) Clostridioides difficile infection (CDI) among adult patients in Canadian Nosocomial Infection Surveillance Program hospitals during 2015-2019. The study encompassed 18,455 CDI cases, 13,735 (74.4%) HA and 4,720 (25.6%) CA. During ...
    Supporting Files Public Domain
  • Geographic Origin and Vertical Transmission of Leishmania infantum Parasites in Hunting Hounds United States
    Geographic Origin and Vertical Transmission of Leishmania infantum Parasites in Hunting Hounds, United States
    Franssen, Susanne U. ;
    Sanders, Mandy J.
    6 2022 | Emerg Infect Dis. 2022; 28(6):1211-1223
    Vertical transmission of leishmaniasis is common but is difficult to study against the background of pervasive vector transmission. We present genomic data from dogs in the United States infected with Leishmania infantum parasites; these infections have persisted in the apparent absence of vector transmission. We demonstrate that these parasites we ...
    Supporting Files Public Domain
921 - 940 / 12467